These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11067745)

  • 21. Luminescence of aequorin is triggered by the binding of two calcium ions.
    Shimomura O
    Biochem Biophys Res Commun; 1995 Jun; 211(2):359-63. PubMed ID: 7794244
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fluorescence- and luminescence-based methods for the determination of affinity and activity of neuropeptide Y2 receptor ligands.
    Ziemek R; Brennauer A; Schneider E; Cabrele C; Beck-Sickinger AG; Bernhardt G; Buschauer A
    Eur J Pharmacol; 2006 Dec; 551(1-3):10-8. PubMed ID: 17027743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Measurement of intracellular calcium in cell populations loaded with aequorin: neurokinin-1 responses in U373MG cells.
    Hedley L; Phagoo SB; James IF
    Anal Biochem; 1996 May; 236(2):270-4. PubMed ID: 8660504
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-type specific calcium signaling by corticotropin-releasing factor type 1 (CRF1) and 2a (CRF2(a)) receptors: phospholipase C-mediated responses in human embryonic kidney 293 but not SK-N-MC neuroblastoma cells.
    Dautzenberg FM; Gutknecht E; Van der Linden I; Olivares-Reyes JA; Dürrenberger F; Hauger RL
    Biochem Pharmacol; 2004 Nov; 68(9):1833-44. PubMed ID: 15450949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Internalization and recycling of 5-HT2A receptors activated by serotonin and protein kinase C-mediated mechanisms.
    Bhattacharyya S; Puri S; Miledi R; Panicker MM
    Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14470-5. PubMed ID: 12388782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
    Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
    Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Delay of intracellular calcium transients using a calcium chelator: application to high-throughput screening of the capsaicin receptor ion channel and G-protein-coupled receptors.
    Grant SK; Bansal A; Mitra A; Feighner SD; Dai G; Kaczorowski GJ; Middleton RE
    Anal Biochem; 2001 Jul; 294(1):27-35. PubMed ID: 11412002
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
    Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
    Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transgenic plant aequorin reports the effects of touch and cold-shock and elicitors on cytoplasmic calcium.
    Knight MR; Campbell AK; Smith SM; Trewavas AJ
    Nature; 1991 Aug; 352(6335):524-6. PubMed ID: 1865907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anxiolytic-like effect of a serotonergic ligand with high affinity for 5-HT1A, 5-HT2A and 5-HT3 receptors.
    Delgado M; Caicoya AG; Greciano V; Benhamú B; López-Rodríguez ML; Fernández-Alfonso MS; Pozo MA; Manzanares J; Fuentes JA
    Eur J Pharmacol; 2005 Mar; 511(1):9-19. PubMed ID: 15777774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation.
    Lopez-Gimenez JF; Vilaró MT; Milligan G
    Mol Pharmacol; 2008 Nov; 74(5):1278-91. PubMed ID: 18703670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the 5-HT2b receptor in evaluation of aequorin detection of calcium mobilization for miniaturized GPCR high-throughput screening.
    Gilchrist MA; Cacace A; Harden DG
    J Biomol Screen; 2008 Jul; 13(6):486-93. PubMed ID: 18566482
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proteolysis of the N-methyl-d-aspartate receptor by calpain in situ.
    Guttmann RP; Sokol S; Baker DL; Simpkins KL; Dong Y; Lynch DR
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1023-30. PubMed ID: 12183659
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cloning, expression, and functional analysis of human dopamine D1 receptors.
    Sun WC; Jin L; Cao Y; Wang LZ; Meng F; Zhu XZ
    Acta Pharmacol Sin; 2005 Jan; 26(1):27-32. PubMed ID: 15659110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a chimeric aequorin molecule expressed in myeloma cells.
    Casadei J; Powell MJ; Kenten JH
    J Biolumin Chemilumin; 1989 Jul; 4(1):346-50. PubMed ID: 2801222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inverse agonist actions of typical and atypical antipsychotic drugs at the human 5-hydroxytryptamine(2C) receptor.
    Rauser L; Savage JE; Meltzer HY; Roth BL
    J Pharmacol Exp Ther; 2001 Oct; 299(1):83-9. PubMed ID: 11561066
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development of a scintillation proximity assay binding method for the human 5-hydroxytryptamine 6 receptor using intact cells.
    Carrick T; Kowal D; Nawoschik S; Zhang G; Chan K; Dunlop J
    Anal Biochem; 2008 Oct; 381(1):27-32. PubMed ID: 18601889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human 5-HT7 serotonin receptor splice variants: constitutive activity and inverse agonist effects.
    Krobert KA; Levy FO
    Br J Pharmacol; 2002 Mar; 135(6):1563-71. PubMed ID: 11906971
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of serotonin 5-HT(2A) receptors in the human cerebellum and alterations in schizophrenia.
    Eastwood SL; Burnet PW; Gittins R; Baker K; Harrison PJ
    Synapse; 2001 Nov; 42(2):104-14. PubMed ID: 11574947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential agonist-mediated internalization of the human 5-hydroxytryptamine 7 receptor isoforms.
    Guthrie CR; Murray AT; Franklin AA; Hamblin MW
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1003-10. PubMed ID: 15716386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.